Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acoustic Bio is a biotechnology company developing a high-throughput platform for cell engineering and therapy manufacturing using acoustic wave technology. The company's proprietary platform utilizes sound waves to manipulate and engineer cells with high precision, aiming to overcome the limitations of traditional viral and chemical transfection methods. By providing a non-viral, gentle, and scalable approach to cell modification, Acoustic Bio seeks to accelerate the development of next-generation CAR-T and other cell-based therapies. The technology is designed to improve cell viability and functional performance while reducing the complexity and cost of biomanufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acoustic Technologies.